These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 35589644

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pathophysiology of inflammatory and autoimmune myopathies.
    Dalakas MC.
    Presse Med; 2011 Apr; 40(4 Pt 2):e237-47. PubMed ID: 21411269
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Idiopathic inflammatory myopathies.
    Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, Mammen AL, Miller FW.
    Nat Rev Dis Primers; 2021 Dec 02; 7(1):86. PubMed ID: 34857798
    [Abstract] [Full Text] [Related]

  • 25. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
    Mescam-Mancini L, Allenbach Y, Hervier B, Devilliers H, Mariampillay K, Dubourg O, Maisonobe T, Gherardi R, Mezin P, Preusse C, Stenzel W, Benveniste O.
    Brain; 2015 Sep 02; 138(Pt 9):2485-92. PubMed ID: 26198592
    [Abstract] [Full Text] [Related]

  • 26. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
    Cherin P.
    Ann Med Interne (Paris); 2000 May 02; 151 Suppl 1():1S48-50. PubMed ID: 10896990
    [Abstract] [Full Text] [Related]

  • 27. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C, Beaufrére AM, Boyer O, Drouot L, Soubrier M, Tournadre A.
    Joint Bone Spine; 2014 Jan 02; 81(1):79-82. PubMed ID: 23953224
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies: effects on clinicopathological features and immunoregulatory genes.
    Dalakas MC.
    Clin Rev Allergy Immunol; 2005 Dec 02; 29(3):255-69. PubMed ID: 16391401
    [Abstract] [Full Text] [Related]

  • 30. Statin-associated anti-HMGCR immune-mediated necrotizing myopathy with dermatomyositis-like features: A case report.
    Lim D, Landon-Cardinal O, Ellezam B, Belisle A, Genois A, Sirois J, Bourré-Tessier J.
    SAGE Open Med Case Rep; 2020 Dec 02; 8():2050313X20984120. PubMed ID: 33447390
    [Abstract] [Full Text] [Related]

  • 31. Statins as a possible cause of inflammatory and necrotizing myopathies.
    Padala S, Thompson PD.
    Atherosclerosis; 2012 May 02; 222(1):15-21. PubMed ID: 22154355
    [Abstract] [Full Text] [Related]

  • 32. Immune Mediated Necrotizing Myopathy: Where do we Stand?
    Mohammed AGA, Gcelu A, Moosajee F, Botha S, Kalla AA.
    Curr Rheumatol Rev; 2019 May 02; 15(1):23-26. PubMed ID: 29623846
    [Abstract] [Full Text] [Related]

  • 33. Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile.
    Preuße C, Goebel HH, Held J, Wengert O, Scheibe F, Irlbacher K, Koch A, Heppner FL, Stenzel W.
    Am J Pathol; 2012 Dec 02; 181(6):2161-71. PubMed ID: 23058368
    [Abstract] [Full Text] [Related]

  • 34. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
    Feldman BM, Rider LG, Reed AM, Pachman LM.
    Lancet; 2008 Jun 28; 371(9631):2201-12. PubMed ID: 18586175
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E.
    Ann Med Interne (Paris); 2001 Nov 28; 152(7):455-64. PubMed ID: 11965087
    [Abstract] [Full Text] [Related]

  • 37. Corticosteroids in Myositis and Scleroderma.
    Postolova A, Chen JK, Chung L.
    Rheum Dis Clin North Am; 2016 Feb 28; 42(1):103-18, ix. PubMed ID: 26611554
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, Meyer A, Tohmé A, Charuel JL, Musset L, Allenbach Y, Benveniste O.
    JAMA Neurol; 2018 Dec 01; 75(12):1528-1537. PubMed ID: 30208379
    [Abstract] [Full Text] [Related]

  • 40. Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis.
    Giannini M, Fiorella ML, Tampoia M, Girolamo F, Fornaro M, Amati A, Lia A, Abbracciavento L, D'Abbicco D, Iannone F.
    Rheumatology (Oxford); 2021 Mar 02; 60(3):1234-1242. PubMed ID: 32911543
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.